Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-06888-4.pdf
Reference59 articles.
1. Taal, W., Bromberg, J. E. & van den Bent, M. J. Chemotherapy in glioma. CNS oncology 4, 179–192 (2015).
2. Riemenschneider, M. J., Jeuken, J. W., Wesseling, P. & Reifenberger, G. Molecular diagnostics of gliomas: state of the art. Acta neuropathologica 120, 567–584 (2010).
3. Khasraw, M. & Lassman, A. B. Advances in the treatment of malignant gliomas. Current oncology reports 12, 26–33 (2010).
4. Oberoi, R. K. et al. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. Neuro-oncology 18, 27–36 (2016).
5. Chamberlain, M. C. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Expert review of neurotherapeutics 10, 1537–1544 (2010).
Cited by 121 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade;Archiv der Pharmazie;2024-07-29
2. Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects;Ageing Research Reviews;2024-07
3. To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges;Journal of Controlled Release;2024-07
4. Lactoferrin Reduces Surfactant Content in the Self-Emulsifying Drug Delivery System;ACS Omega;2024-03-11
5. A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus;Expert Opinion on Drug Delivery;2024-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3